As of December 2024, Medigen Biotechnology has a market cap of $133.39M. This makes Medigen Biotechnology the world's 18320th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $176.00M | -7.81% |
2023 | $190.92M | 33.33% |
2022 | $143.19M | -41.46% |
2021 | $244.61M | -3.04% |
2020 | $252.28M | -4.67% |
2019 | $264.64M | 37.85% |
2018 | $191.98M | 27.26% |
2017 | $150.86M | -55.36% |
2016 | $337.94M | -7.25% |
2015 | $364.36M | -48.65% |
2014 | $709.54M | -16.33% |
2013 | $848.04M | 29.10% |
2012 | $656.89M | 306.16% |
2011 | $161.73M | 155.48% |
2010 | $63.30M | 0.00% |
2009 | $63.30M | -7.19% |
2008 | $68.21M | -60.98% |
2007 | $174.80M | - |